---
title: "This Danaos Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295107347.md"
description: "Wall Street analysts upgraded five stocks on Thursday: Raymond James upgraded Sabra Health Care REIT to Market Perform; Deutsche Bank upgraded Coupang to Buy with a lowered price target; Freedom Broker upgraded Danaos Corp to Buy, raising its target to $155; Jefferies upgraded J&J Snack Foods to Buy, increasing the target to $101; and JP Morgan upgraded Charles River Labs to Overweight, boosting the target to $310."
datetime: "2026-08-06T12:15:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295107347.md)
  - [en](https://longbridge.com/en/news/295107347.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295107347.md)
---

# This Danaos Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Raymond James analyst David Rodgers upgraded **Sabra Health Care REIT Inc** (NASDAQ:SBRA) from Underperform to Market Perform. Sabra Health Care closed at $21.08 on Wednesday. See how other analysts view this stock.
-   Deutsche Bank analyst Peter Milliken upgraded **Coupang Inc** (NYSE:CPNG) from Hold to Buy and cut the price target from $23 to $21.5. Coupang shares closed at $16.00 on Wednesday. See how other analysts view this stock.
-   Freedom Broker analyst Sergey Glinyanov upgraded **Danaos Corp** (NYSE:DAC) from Hold to Buy and boosted the price target from $140 to $155. Danaos closed at $138.62 on Wednesday. See how other analysts view this stock.
-   Jefferies analyst Scott Marks upgraded **J&J Snack Foods Corp** (NASDAQ:JJSF) from Hold to Buy and raised the price target from $81 to $101. J&J Snack Foods shares closed at $84.66 on Wednesday. See how other analysts view this stock.
-   JP Morgan analyst Casey Woodring upgraded **Charles River** (NYSE:CRL) from Neutral to Overweight and boosted the price target from $180 to $310. Charles River shares closed at $260.72 on Wednesday. See how other analysts view this stock.

Considering buying DAC stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [JJSF.US](https://longbridge.com/en/quote/JJSF.US.md)
- [CPNG.US](https://longbridge.com/en/quote/CPNG.US.md)
- [SBRA.US](https://longbridge.com/en/quote/SBRA.US.md)
- [DAC.US](https://longbridge.com/en/quote/DAC.US.md)
- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [CPNX.US](https://longbridge.com/en/quote/CPNX.US.md)

## Related News & Research

- [Coupang Chief Accounting Officer Jonathan D. Lee melepas saham senilai USD 88.876,94](https://longbridge.com/en/news/295577505.md)
- [Coupang, Inc. (NYSE:CPNG) Given Average Recommendation of "Hold" by Analysts](https://longbridge.com/en/news/295109176.md)
- [Charles River Labs CEVP Shannon Parisotto disposes of shares worth $1,038,051.24](https://longbridge.com/en/news/295844385.md)
- [TD Cowen Reaffirms Their Buy Rating on Charles River Labs (CRL)](https://longbridge.com/en/news/295351253.md)
- [Danaos (NYSE:DAC) Issues Quarterly Earnings Results, Beats Estimates By $0.49 EPS](https://longbridge.com/en/news/294741773.md)